2-氨基-6-(乙基氨基)苯甲腈 | 63365-27-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-6-(乙基氨基)苯甲腈
• 英文名称: 2-amino-6-(ethylamino)benzonitrile
• CAS: 63365-27-5
• 化学式: C₉H₁₁N₃
• 分子量: 161.206
• InChiKey: XIDLKNXPGSMUDN-UHFFFAOYSA-N

物化性质

• 沸点：
  373.4±37.0 °C(Predicted)
• 密度：
  1.12±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  61.8
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2926909090

反应信息

• 作为反应物：
  描述：

  2-氨基-6-(乙基氨基)苯甲腈 在 吡啶 、 ammonium hydroxide 作用下， 以 甲醇 为溶剂， 反应 4.0h， 生成 2-(Ethylamino)-6-(hydroxyacetylamino)benzonitrile
  参考文献：
  名称：

  Novel antiallergic and antiinflammatory agents. Part I: Synthesis and pharmacology of glycolic amide derivatives

  摘要：

  A series of mono-glycoloylamino derivatives was synthesized by treatment of the corresponding aromatic monoamine derivatives with glycoloyl chloride derivatives in pyridine or dichloromethane, in the presence of a base such as triethylamine or pyridine. Hydrolysis of acetoxy compounds in aqueous ammonia and methanol solution produced hydroxy derivatives with ease. These compounds were tested in the rat PCA (passive cutaneous anaphylaxis) assay by oral administration. Thiazole and thiadiazole derivatives showed moderate inhibition in this assay. In contrast, benzothiazole and benzonitrile derivatives exhibited marked inhibition. In particular, compound 5t also showed marked inhibition of eosinophil adhesion to TNF (tumor necrosis factor) -alpha-treated HUVEC (human umbilical vein endothelial cells) in the range of 10(-8)-10(-5) M. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)00065-0
• 作为产物：
  描述：

  2,6-二硝基苯腈 在 盐酸 、 铁粉 作用下， 以 甲醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 0.42h， 生成 2-氨基-6-(乙基氨基)苯甲腈
  参考文献：
  名称：

  N-（氨基苯基）草酰胺酸和酯类作为有效的口服活性抗过敏剂。

  摘要：

  DOI：

  10.1021/jm00138a020

文献信息

• Novel substituted acetamide compounds and use as anti-allergic agents
  申请人：Toyo Boseki Kabushiki Kaisha

  公开号：US05041462A1

  公开（公告）日：1991-08-20

  Novel substituted acetamide compounds of the formula ##STR1## wherein R.sup.1 is hydrogen atom, a lower alkyl group, a lower acyl group, or an aryl group; R.sup.2 is cyano group or aminocarbonyl group; R.sup.3 is a halogen atom, nitro group, a lower alkoxy group, a group of the formula: --NR.sup.4 R.sup.5 (wherein R.sup.4 is hydrogen atom, a lower alkyl group or a group of the formula: --COCH.sub.2 OR.sup.1 ; R.sup.5 is hydrogen atom or a lower alkyl group), or a cyclic amino group of the formula: ##STR2## (wherein R.sup.6 and R.sup.7 are each an alkylene group having 1 to 3 carbon atoms, and X is oxygen atom or methylene), or a pharmaceutically acceptable acid addition salt thereof, which have excellent anti-allergic activity and are useful for the prophylaxis and treatment of various allergic diseases, and a pharmaceutical composition containing the amide compound as set forth above as an active ingredient.

  该专利涉及一种替代乙酰胺化合物，其化学式为 ##STR1## 其中 R.sup.1 是氢原子，低碳基，低酰基或芳基；R.sup.2 是氰基或氨基甲酰基；R.sup.3 是卤素原子，硝基，低烷氧基，公式：--NR.sup.4 R.sup.5（其中R.sup.4是氢原子，低碳基或公式：--COCH.sub.2 OR.sup.1；R.sup.5是氢原子或低碳基），或公式：##STR2##（其中R.sup.6和R.sup.7均为具有1至3个碳原子的烷基，X为氧原子或亚甲基），或其药学上可接受的酸加成盐。该化合物具有出色的抗过敏活性，可用于预防和治疗各种过敏性疾病，并且一种含有上述酰胺化合物作为活性成分的制药组合物。
• 2-Cyano-3- or 4-(substituted amino)oxanilic acid derivatives
  申请人：American Home Products Corporation

  公开号：US04087606A1

  公开（公告）日：1978-05-02

  The 2-cyano-3-or 4-(substituted amino) oxanilic acid derivatives of the formula: ##STR1## in which the group ##STR2## appears in the designated 3- or 4- position and R is --H; an alkali metal; .sup.+ NH.sub.4 ; alkyl of 1 to 6 carbon atoms, inclusive; aralkyl of 7 or 8 carbon atoms; or cycloalkyl of 5 or 6 carbon atoms; R.sup.1 is --H or alkyl of 1 to 9 carbon atoms; R.sup.2 is --H, alkyl of 1 to 9 carbon atoms or cycloalkyl of 3 to 6 carbon atoms; R.sup.1 and R.sup.2, together, with the nitrogen atom to which they are attached, are aziridinyl, azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, 4-lower alkyl-piperazinyl, morpholino or thiomorpholino; And pharmaceutically acceptable acid addition salts thereof are anti-allergic agents.

  公式为：##STR1##的2-氰基-3-或4-(取代氨基)氧化苯乙酸衍生物，其中基团##STR2##出现在指定的3-或4-位置，R为--H；碱金属；.sup.+ NH.sub.4；1至6个碳原子的烷基，包括；7或8个碳原子的芳基烷基；或5或6个碳原子的环烷基；R.sup.1为--H或1至9个碳原子的烷基；R.sup.2为--H，1至9个碳原子的烷基或3至6个碳原子的环烷基；R.sup.1和R.sup.2与它们附着的氮原子一起，是氮杂环丙基，氮杂环戊基，吡咯烷基，哌啶基，哌嗪基，4-低烷基哌嗪基，吗啉或硫代吗啉；以及其药学上可接受的酸盐是抗过敏剂。
• 2-Cyano-3-or 4-(substituted amino)oxanilic acid derivatives
  申请人：American Home Products Corporation

  公开号：US04054591A1

  公开（公告）日：1977-10-18

  The 2-cyano-3-or 4-(substituted amino)oxanilic acid derivatives of the formula: ##STR1## in which the group ##STR2## appears in the designated 3- or 4- position and R is -H; an alkali metal; .sup.+ NH.sub.4 ; alkyl of 1 to 6 carbon atoms, inclusive; aralkyl of 7 or 8 carbon atoms; or cycloalkyl of 5 or 6 carbon atoms; R.sup.1 is --H or alkyl of 1 to 9 carbon atoms; R.sup.2 is --H, alkyl of 1 to 9 carbon atoms or cycloalkyl of 3 to 6 carbon atoms; R.sup.1 and R.sup.2, together, with the nitrogen atom to which they are attached, are aziridinyl, azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, 4-lower alkyl-piperazinyl, morpholino or thiomorpholino; and pharmaceutically acceptable acid addition salts thereof are anti-allergic agents.

  公式为：##STR1## 的2-氰基-3-或4-(取代氨基)氧化邻苯二甲酸衍生物，其中组 ##STR2## 出现在指定的3-或4-位置，R为-H；碱金属；.sup.+ NH.sub.4；1至6个碳原子的烷基，包括；7或8个碳原子的芳基烷基；或5或6个碳原子的环烷基；R.sup.1为--H或1至9个碳原子的烷基；R.sup.2为--H，1至9个碳原子的烷基或3至6个碳原子的环烷基；R.sup.1和R.sup.2与它们所连接的氮原子一起，是氮杂环丙烷基，氮杂环戊烷基，吡咯烷基，哌啶基，哌嗪基，4-低烷基哌嗪基，吗啉基或硫代吗啉基；以及其药学上可接受的酸盐是抗过敏剂。
• MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH
  申请人：Tachdjian Catherine

  公开号：US20110224155A1

  公开（公告）日：2011-09-15

  The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors, and modifiers capable of modulating chemosensory receptors and their ligands. The present invention also includes modifiers of chemosensory receptors and their ligands having Formula (I), its subgenus, and specific compounds. Furthermore, the present invention includes ingestible compositions comprising the modifiers of chemosensory receptors and their ligands and methods of using the modifiers of chemosensory receptors and their ligands to enhance the sweet taste of an ingestible composition or treat a condition associated with a chemosensory receptor. In addition, the present invention include processes for preparing the modifiers of chemosensory receptors and their ligands.

  本发明包括识别化学感受受体及其配体的修饰剂的方法，例如通过确定测试实体是否适合与化学感受受体的捕蝇草结构域中的一个或多个相互作用位点发生相互作用，并且能够调节化学感受受体及其配体的修饰剂。本发明还包括化学感受受体及其配体的修饰剂，其具有式（I）、其亚属和具体化合物。此外，本发明还包括包含化学感受受体及其配体的修饰剂的可食用组合物以及使用化学感受受体及其配体的修饰剂增强可食用组合物的甜味或治疗与化学感受受体相关的疾病的方法。此外，本发明还包括制备化学感受受体及其配体的修饰剂的过程。
• Modulation of chemosensory receptors and ligands associated therewith
  申请人：Tachdjian Catherine

  公开号：US08633186B2

  公开（公告）日：2014-01-21

  The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors, and modifiers capable of modulating chemosensory receptors and their ligands. The present invention also includes modifiers of chemosensory receptors and their ligands having Formula (I), its subgenus, and specific compounds. Furthermore, the present invention includes ingestible compositions comprising the modifiers of chemosensory receptors and their ligands and methods of using the modifiers of chemosensory receptors and their ligands to enhance the sweet taste of an ingestible composition or treat a condition associated with a chemosensory receptor. In addition, the present invention include processes for preparing the modifiers of chemosensory receptors and their ligands.

  本发明涉及识别化学感受器及其配体的修饰剂的方法，例如，通过确定测试实体是否适合与化学感受器的食虫植物结构域内的一个或多个相互作用位点相互作用来确定。本发明还包括能够调节化学感受器及其配体的修饰剂。本发明还包括具有公式（I）、其亚属和特定化合物的化学感受器及其配体的修饰剂。此外，本发明包括包含化学感受器及其配体的修饰剂的可食用组合物，并使用化学感受器及其配体的修饰剂来增强可食用组合物的甜味或治疗与化学感受器相关的疾病的方法。此外，本发明还包括制备化学感受器及其配体的修饰剂的方法。